Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001376113.1(ZBTB38):c.1321G>A(p.Gly441Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000675 in 1,614,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
ZBTB38 (HGNC:26636): (zinc finger and BTB domain containing 38) The protein encoded by this gene is a zinc finger transcriptional activator that binds methylated DNA. The encoded protein can form homodimers or heterodimers through the zinc finger domains. In mouse, inhibition of this protein has been associated with apoptosis in some cell types. [provided by RefSeq, Jun 2010]
Uncertain significance, criteria provided, single submitter
clinical testing
Ambry Genetics
Jul 11, 2023
The c.1321G>A (p.G441R) alteration is located in exon 8 (coding exon 1) of the ZBTB38 gene. This alteration results from a G to A substitution at nucleotide position 1321, causing the glycine (G) at amino acid position 441 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of phosphorylation at S438 (P = 0.1234);Gain of phosphorylation at S438 (P = 0.1234);Gain of phosphorylation at S438 (P = 0.1234);Gain of phosphorylation at S438 (P = 0.1234);Gain of phosphorylation at S438 (P = 0.1234);Gain of phosphorylation at S438 (P = 0.1234);